| Year |
Citation |
Score |
| 2023 |
Stecklein SR, Barlow W, Pusztai L, Timms K, Kennedy R, Logan GE, Seitz R, Badve S, Gökmen-Polar Y, Porter P, Linden H, Tripathy D, Hortobagyi GN, Godwin AK, Thompson A, et al. Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency. Jco Precision Oncology. 7: e2300197. PMID 37972336 DOI: 10.1200/PO.23.00197 |
0.383 |
|
| 2023 |
Kazerouni AS, Peterson LM, Jenkins I, Novakova-Jiresova A, Linden HM, Gralow JR, Hockenbery DM, Mankoff DA, Porter PL, Partridge SC, Specht JM. Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer. Breast Cancer Research : Bcr. 25: 138. PMID 37946201 DOI: 10.1186/s13058-023-01722-4 |
0.474 |
|
| 2022 |
Fontvieille E, His M, Biessy C, Navionis AS, Torres-Mejía G, Ángeles-Llerenas A, Alvarado-Cabrero I, Sánchez GI, Navarro E, Cortes YR, Porras C, Rodriguez AC, Garmendia ML, Soto JL, Moyano L, ... Porter PL, et al. Inflammatory biomarkers and risk of breast cancer among young women in Latin America: a case-control study. Bmc Cancer. 22: 877. PMID 35948877 DOI: 10.1186/s12885-022-09975-6 |
0.781 |
|
| 2022 |
Romieu I, Khandpur N, Katsikari A, Biessy C, Torres-Mejía G, Ángeles-Llerenas A, Alvarado-Cabrero I, Sánchez GI, Maldonado ME, Porras C, Rodriguez AC, Garmendia ML, Chajés V, Aglago EK, Porter PL, et al. Consumption of industrial processed foods and risk of premenopausal breast cancer among Latin American women: the PRECAMA study. Bmj Nutrition, Prevention & Health. 5: 1-9. PMID 35814719 DOI: 10.1136/bmjnph-2021-000335 |
0.407 |
|
| 2022 |
Jordahl KM, Malone KE, Baglia ML, Flanagan MR, Tang MC, Porter PL, Li CI. Alcohol consumption, smoking, and invasive breast cancer risk after ductal carcinoma in situ. Breast Cancer Research and Treatment. PMID 35347551 DOI: 10.1007/s10549-022-06573-9 |
0.451 |
|
| 2021 |
Bayani J, Poncet C, Crozier C, Neven A, Piper T, Cunningham C, Sobol M, Aebi S, Benstead K, Bogler O, Dal Lago L, Fraser J, Hilbers F, Hedenfalk I, Korde L, ... ... Porter P, et al. Evaluation of multiple transcriptomic gene risk signatures in male breast cancer. Npj Breast Cancer. 7: 98. PMID 34312396 DOI: 10.1038/s41523-021-00301-0 |
0.402 |
|
| 2021 |
Li CI, Flanagan MR, Tang MC, Porter PL, Malone KE. Bisphosphonate Use and Breast Cancer Risk among Women with Ductal Carcinoma In Situ. Cancer Research. PMID 33762354 DOI: 10.1158/0008-5472.CAN-20-4100 |
0.52 |
|
| 2021 |
Li CI, Zhang Y, Cieslik M, Wu YM, Xiao L, Cobain EF, Tang MC, Cao X, Porter PL, Guenthoer J, Robinson DR, Chinnaiyan AM. Cancer cell-intrinsic and immunological phenotypes determine clinical outcomes in basal-like breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33753452 DOI: 10.1158/1078-0432.CCR-20-3890 |
0.79 |
|
| 2020 |
His M, Biessy C, Torres-Mejía G, Ángeles-Llerenas A, Alvarado-Cabrero I, Sánchez GI, Borrero M, Porras C, Rodriguez AC, Garmendia ML, Olivier M, Porter PL, Lin M, Gunter MJ, Romieu I, et al. Anthropometry, body shape in early-life and risk of premenopausal breast cancer among Latin American women: results from the PRECAMA study. Scientific Reports. 10: 2294. PMID 32042008 DOI: 10.1038/s41598-020-59056-6 |
0.43 |
|
| 2020 |
Bayani J, Poncet C, Crozier C, Trinh QM, Hopkins M, Uwimana AL, Piper T, Cunningham C, Sobol M, Aebi S, Benstead K, Bogler O, Lago LD, Hilbers F, Hedenfalk I, ... ... Porter P, et al. Abstract P4-10-03: The genomic landscape of male breast cancers using the oncomine comprehensive assay for actionable mutations Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P4-10-03 |
0.491 |
|
| 2019 |
Romieu I, Biessy C, Torres-Mejía G, Ángeles-Llerenas A, Sánchez GI, Borrero M, Ossa CA, Porras C, Rodríguez AC, Ocampo R, Garmendia ML, Bustamante E, Olivier M, Porter P, Rinaldi S, et al. Project profile: a multicenter study on breast cancer in young women in Latin America (PRECAMA study). Salud Publica De Mexico. 61: 601-608. PMID 31661737 DOI: 10.21149/10466 |
0.575 |
|
| 2019 |
Sharma P, Barlow WE, Godwin AK, Parkes EE, Knight LA, Walker SM, Kennedy RD, Harkin DP, Logan GE, Steele CJ, Lambe SM, Badve S, Gökmen-Polar Y, Pathak HB, Isakova K, ... ... Porter P, et al. Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900693. PMID 31657982 DOI: 10.1200/Jco.19.00693 |
0.509 |
|
| 2019 |
Rivkind N, Stepanenko V, Belukha I, Guenthoer J, Kopecky KJ, Kulikov S, Kurnosova I, Onstad L, Porter P, Shklovskiy-Kordi N, Troshin V, Voillequé P, Davis S. Female breast cancer risk in Bryansk Oblast, Russia, following prolonged low dose rate exposure to radiation from the Chernobyl power station accident. International Journal of Epidemiology. PMID 31628796 DOI: 10.1093/Ije/Dyz214 |
0.737 |
|
| 2019 |
Dvinge H, Guenthoer J, Porter PL, Bradley RK. RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing. Genome Research. PMID 31434678 DOI: 10.1101/Gr.246678.118 |
0.712 |
|
| 2019 |
Olivier M, Bouaoun L, Villar S, Robitaille A, Cahais V, Heguy A, Byrnes G, Le Calvez-Kelm F, Torres-Mejía G, Alvarado-Cabrero I, Imani-Razavi FS, Inés Sánchez G, Jaramillo R, Porras C, Rodriguez AC, ... ... Porter P, et al. Molecular features of premenopausal breast cancers in Latin American women: Pilot results from the PRECAMA study. Plos One. 14: e0210372. PMID 30653559 DOI: 10.1371/Journal.Pone.0210372 |
0.757 |
|
| 2019 |
Bayani J, Poncet C, Yao C, Crozier C, Anouk N, Piper T, Cunningham C, Sobol M, Aebi S, Benstead K, Bogler O, Lago LD, Fraser J, Hilbers F, Hedenfalk I, ... ... Porter P, et al. Abstract P6-19-01: Evaluation of multiple transcriptomic gene risk signatures in male breast cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-P6-19-01 |
0.544 |
|
| 2019 |
Sharma P, Barlow W, Hout, Seitz R, Bailey D, Godwin A, Pathak H, Timms K, Solimeno C, Linden H, Porter P, Tripathy D, Hortobagyi G, Thompson A, Pusztai L, et al. Abstract P4-08-06: Impact of molecular subtypes on long-term outcomes in triple-negative breast cancer (TNBC) patients treated with adjuvant AC chemotherapy on SWOG S9313 Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P4-08-06 |
0.514 |
|
| 2018 |
Flanagan MR, Tang MC, Baglia ML, Porter PL, Malone KE, Li CI. Relationship Between Anthropometric Factors and Risk of Second Breast Cancer Among Women With a History of Ductal Carcinoma In Situ. Jnci Cancer Spectrum. 2: pky020. PMID 31360852 DOI: 10.1093/jncics/pky020 |
0.465 |
|
| 2018 |
Baglia ML, Tang MC, Malone KE, Porter P, Li CI. Reproductive and menopausal factors and risk of second primary breast cancer after in situ breast carcinoma. Cancer Causes & Control : Ccc. PMID 30539315 DOI: 10.1007/S10552-018-1119-8 |
0.647 |
|
| 2018 |
Peterson LM, Kurland BF, Schubert EK, Link JM, Gadi VK, Specht JM, Eary JF, Porter P, Shankar LK, Mankoff DA, Linden HM. Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC). Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 30324461 DOI: 10.1007/S11307-018-1287-7 |
0.401 |
|
| 2018 |
Romieu I, Biessy C, Carayol M, His M, Torres-Mejía G, Ángeles-Llerenas A, Sánchez GI, Jaramillo R, Navarro E, Porras C, Ocampo R, Rodriguez AC, Garmendia ML, Bustamante E, Olivier M, ... Porter P, et al. Reproductive factors and molecular subtypes of breast cancer among premenopausal women in Latin America: the PRECAMA study. Scientific Reports. 8: 13109. PMID 30166604 DOI: 10.1038/S41598-018-31393-7 |
0.416 |
|
| 2018 |
Baglia ML, Cook LS, Tang MT, Wiggins C, Hill D, Porter P, Li CI. Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer. International Journal of Cancer. PMID 29708591 DOI: 10.1002/ijc.31575 |
0.547 |
|
| 2018 |
Pelekanou V, Barlow WE, Nahleh Z, Wasserman B, Lo YC, von Wahlde MK, Hayes DF, Hortobagyi GN, Gralow JR, Tripathy D, Porter PL, Szekely B, Hatzis C, Rimm DL, Pusztai L. Tumor infiltrating lymphocytes and PD-L1 expression in pre- and post-treatment breast cancers in the SWOG S0800 Phase II neoadjuvant chemotherapy trial. Molecular Cancer Therapeutics. PMID 29588392 DOI: 10.1158/1535-7163.Mct-17-1005 |
0.306 |
|
| 2018 |
Paskett ED, Caan BJ, Johnson L, Bernardo BM, Young GS, Pennell ML, Ray RM, Kroenke CH, Porter PL, Anderson GL. The Women's Health Initiative (WHI) Life and Longevity After Cancer (LILAC) Study: Description and Baseline Characteristics of Participants. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29378785 DOI: 10.1158/1055-9965.Epi-17-0581 |
0.435 |
|
| 2018 |
Baglia ML, Tang MC, Malone KE, Porter P, Li CI. Family History and Risk of Second Primary Breast Cancer after In Situ Breast Carcinoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29339357 DOI: 10.1158/1055-9965.Epi-17-0837 |
0.628 |
|
| 2017 |
Malone KE, Korde LA, Doody DR, Hsu L, Porter PL. Bisphosphonate use and risk of recurrence, second primary breast cancer, and breast cancer mortality in a population-based cohort of breast cancer patients. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29254937 DOI: 10.1158/1055-9965.EPI-17-0556 |
0.57 |
|
| 2016 |
Atkinson C, Ray RM, Li W, Lin MG, Gao DL, Shannon J, Stalsberg H, Porter PL, Frankenfeld CL, Wähälä K, Thomas DB, Lampe JW. Plasma equol concentration is not associated with breast cancer and fibrocystic breast conditions among women in Shanghai, China. Nutrition Research (New York, N.Y.). 36: 863-871. PMID 27440541 DOI: 10.1016/J.Nutres.2016.03.008 |
0.476 |
|
| 2016 |
Scheel JR, Peacock S, Orem J, Bugeza S, Muyinda Z, Porter PL, Wood WC, Comis RL, Lehman CD. Improving Breast Ultrasound Interpretation in Uganda Using a Condensed Breast Imaging Reporting and Data System. Academic Radiology. PMID 27325412 DOI: 10.1016/j.acra.2016.05.018 |
0.435 |
|
| 2016 |
Chen L, Li CI, Tang MC, Porter P, Hill DA, Wiggins CL, Cook LS. Reproductive factors and risk of luminal, HER2-overexpressing and triple negative breast cancer among multiethnic women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27307466 DOI: 10.1158/1055-9965.Epi-15-1104 |
0.6 |
|
| 2016 |
Chen L, Cook LS, Tang MC, Porter PL, Hill DA, Wiggins CL, Li CI. Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer. Breast Cancer Research and Treatment. PMID 27220749 DOI: 10.1007/s10549-016-3825-9 |
0.485 |
|
| 2016 |
Bluestein BM, Morrish F, Graham DJ, Guenthoer J, Hockenbery D, Porter PL, Gamble LJ. An unsupervised MVA method to compare specific regions in human breast tumor tissue samples using ToF-SIMS. The Analyst. 141: 1947-57. PMID 26878076 DOI: 10.1039/C5An02406D |
0.714 |
|
| 2016 |
Rodler ET, Kurland BF, Griffin M, Gralow JR, Porter P, Yeh RF, Gadi VK, Guenthoer J, Beumer JH, Korde L, Stychor S, Kiesel B, Linden HM, Thompson JA, Swisher EM, et al. Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26801247 DOI: 10.1158/1078-0432.Ccr-15-2137 |
0.784 |
|
| 2016 |
Lehman CD, Lee JM, DeMartini WB, Hippe DS, Rendi MH, Kalish G, Porter P, Gralow J, Partridge SC. Screening MRI in Women With a Personal History of Breast Cancer. Journal of the National Cancer Institute. 108. PMID 26744477 DOI: 10.1093/jnci/djv349 |
0.486 |
|
| 2016 |
Scheel JR, Nealey EM, Orem J, Bugeza S, Muyinda Z, Nathan RO, Porter PL, Lehman CD. ACR BI-RADS Use in Low-Income Countries: An Analysis of Diagnostic Breast Ultrasound Practice in Uganda. Journal of the American College of Radiology : Jacr. 13: 163-9. PMID 26419306 DOI: 10.1016/j.jacr.2015.07.035 |
0.378 |
|
| 2016 |
Thompson B, Beresford SA, Coronado GD, Neuhouser M, Li CI, Cook LS, Porter P. Abstract IA13: Understanding and preventing breast cancer disparities in Latinas Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-Ia13 |
0.602 |
|
| 2016 |
Specht J, Partridge S, Chai X, Novakova A, Peterson L, Shields A, Guenthoer J, Linden H, Gralow J, Gadi V, Korde L, Hills D, Hsu L, Hockenbery D, Kinahan P, ... ... Porter P, et al. Abstract P5-01-02: Multimodality molecular imaging with dynamic 18F-fluorodeoxyglucose positron emission tomography (FDG PET) and MRI to evaluate response and resistance to neoadjuvant chemotherapy (NAC) Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P5-01-02 |
0.738 |
|
| 2016 |
Li CI, Chen L, Tang M, Porter P, Cook L. Abstract 1747: Relationships between anthropometric and reproductive factors and risks of triple-negative and HER2-overexpressing breast cancers Cancer Research. 76: 1747-1747. DOI: 10.1158/1538-7445.Am2016-1747 |
0.621 |
|
| 2015 |
Gamble LJ, Graham DJ, Bluestein B, Whitehead NP, Hockenbery D, Morrish F, Porter P. ToF-SIMS of tissues: "lessons learned" from mice and women. Biointerphases. 10: 019008. PMID 25708638 DOI: 10.1116/1.4907860 |
0.346 |
|
| 2014 |
Zhao H, Faltermeier CM, Mendelsohn L, Porter PL, Clurman BE, Roberts JM. Mislocalization of p27 to the cytoplasm of breast cancer cells confers resistance to anti-HER2 targeted therapy. Oncotarget. 5: 12704-14. PMID 25587029 DOI: 10.18632/Oncotarget.2871 |
0.413 |
|
| 2014 |
Cai X, Dai Z, Reeves RS, Caballero-Benitez A, Duran KL, Delrow JJ, Porter PL, Spies T, Groh V. Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells. Plos One. 9: e108942. PMID 25291178 DOI: 10.1371/Journal.Pone.0108942 |
0.437 |
|
| 2014 |
Li CI, Daling JR, Haugen KL, Tang MT, Porter PL, Malone KE. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age. Breast Cancer Research and Treatment. 145: 481-9. PMID 24748570 DOI: 10.1007/S10549-014-2960-4 |
0.466 |
|
| 2014 |
Beaber EF, Malone KE, Tang MT, Barlow WE, Porter PL, Daling JR, Li CI. Oral contraceptives and breast cancer risk overall and by molecular subtype among young women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 755-64. PMID 24633144 DOI: 10.1158/1055-9965.Epi-13-0944 |
0.49 |
|
| 2014 |
Peterson LM, Kurland BF, Schubert EK, Link JM, Gadi VK, Specht JM, Eary JF, Porter P, Shankar LK, Mankoff DA, Linden HM. A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC). Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 431-40. PMID 24170452 DOI: 10.1007/S11307-013-0699-7 |
0.35 |
|
| 2014 |
Rodler ET, Gralow J, Kurland BF, Griffin M, Yeh R, Thompson JA, Porter P, Swisher EM, Gadi VK, Korde LA, Linden HM, Ellis GK, Shepherd SP, Giranda VL, Chai X, et al. Phase I: Veliparib with cisplatin (CP) and vinorelbine (VNR) in advanced triple-negative breast cancer (TNBC) and/or BRCA mutation-associated breast cancer. Journal of Clinical Oncology. 32: 2569-2569. DOI: 10.1200/Jco.2014.32.15_Suppl.2569 |
0.598 |
|
| 2013 |
Li CI, Daling JR, Tang MT, Haugen KL, Porter PL, Malone KE. Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years. Jama Internal Medicine. 173: 1629-37. PMID 23921840 DOI: 10.1001/Jamainternmed.2013.9071 |
0.519 |
|
| 2013 |
McDougall JA, Malone KE, Daling JR, Cushing-Haugen KL, Porter PL, Li CI. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1529-37. PMID 23833125 DOI: 10.1158/1055-9965.EPI-13-0414 |
0.446 |
|
| 2013 |
Sgroi DC, Carney E, Zarrella E, Steffel L, Binns SN, Finkelstein DM, Szymonifka J, Bhan AK, Shepherd LE, Zhang Y, Schnabel CA, Erlander MG, Ingle JN, Porter P, Muss HB, et al. Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker. Journal of the National Cancer Institute. 105: 1036-42. PMID 23812955 DOI: 10.1093/Jnci/Djt146 |
0.487 |
|
| 2013 |
Kamineni A, Anderson ML, White E, Taplin SH, Porter P, Ballard-Barbash R, Malone K, Buist DS. Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population. Cancer Causes & Control : Ccc. 24: 305-12. PMID 23224272 DOI: 10.1007/S10552-012-0115-7 |
0.558 |
|
| 2013 |
Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age. Breast Cancer Research and Treatment. 137: 579-87. PMID 23224237 DOI: 10.1007/S10549-012-2365-1 |
0.507 |
|
| 2013 |
Porter P. Abstract ES05-1: Global trends in breast cancer incidence and mortality Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-Es05-1 |
0.608 |
|
| 2012 |
Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I, True L, Nelson PS. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nature Medicine. 18: 1359-68. PMID 22863786 DOI: 10.1038/Nm.2890 |
0.328 |
|
| 2012 |
Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE. Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age. Cancer Research. 72: 2028-35. PMID 22369929 DOI: 10.1158/0008-5472.Can-11-4064 |
0.551 |
|
| 2012 |
Amon LM, Pitteri SJ, Li CI, McIntosh M, Ladd JJ, Disis M, Porter P, Wong CH, Zhang Q, Lampe P, Prentice RL, Hanash SM. Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer. Cancer Research. 72: 1935-42. PMID 22367215 DOI: 10.1158/0008-5472.Can-11-3266 |
0.483 |
|
| 2012 |
Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, O'Meara ES, Li CI. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Annals of Epidemiology. 22: 340-8. PMID 22366170 DOI: 10.1016/j.annepidem.2012.02.002 |
0.51 |
|
| 2012 |
Guenthoer J, Diede SJ, Tanaka H, Chai X, Hsu L, Tapscott SJ, Porter PL. Assessment of palindromes as platforms for DNA amplification in breast cancer. Genome Research. 22: 232-45. PMID 21752925 DOI: 10.1101/Gr.117226.110 |
0.779 |
|
| 2011 |
Sgroi D, Carney E, Richardson E, Steffel L, Binns SN, Finkelstein DM, Shepherd LE, Kesty NC, Schnabel C, Erlander MG, Ingle JN, Porter P, Paik S, Muss HB, Pritchard KI, et al. Prediction of late recurrences by breast cancer index in the NCIC CTG MA.17 cohort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2. PMID 27958176 DOI: 10.1200/Jco.2011.29.27_Suppl.2 |
0.614 |
|
| 2011 |
Malone KE, Daling JR, Doody DR, O'Brien C, Resler A, Ostrander EA, Porter PL. Family history of breast cancer in relation to tumor characteristics and mortality in a population-based study of young women with invasive breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 2560-71. PMID 21960690 DOI: 10.1158/1055-9965.Epi-11-0781 |
0.472 |
|
| 2011 |
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV, Rieger PT, Shockney LD, Shulman LN, Soldak T, Thomas DB, et al. Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative. Breast (Edinburgh, Scotland). 20: S20-9. PMID 21376593 DOI: 10.1016/J.Breast.2011.02.007 |
0.466 |
|
| 2011 |
Loo LW, Wang Y, Flynn EM, Lund MJ, Bowles EJ, Buist DS, Liff JM, Flagg EW, Coates RJ, Eley JW, Hsu L, Porter PL. Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women. Breast Cancer Research and Treatment. 127: 297-308. PMID 21264507 DOI: 10.1007/S10549-010-1297-X |
0.561 |
|
| 2011 |
Phipps AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers Cancer Causes and Control. 22: 399-405. PMID 21184265 DOI: 10.1007/s10552-010-9709-0 |
0.529 |
|
| 2011 |
Reding KW, Doody DR, McTiernan A, Hsu L, Davis S, Daling JR, Porter PL, Malone KE. Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer Breast Cancer Research and Treatment. 126: 749-761. PMID 20878463 DOI: 10.1007/S10549-010-1174-7 |
0.346 |
|
| 2011 |
Phipps AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI. Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk Breast Cancer Research and Treatment. 126: 671-678. PMID 20814817 DOI: 10.1007/s10549-010-1148-9 |
0.544 |
|
| 2010 |
Nelson ZC, Ray RM, Wu C, Stalsberg H, Porter P, Lampe JW, Shannon J, Horner N, Li W, Wang W, Hu Y, Gao D, Thomas DB. Fruit and vegetable intakes are associated with lower risk of breast fibroadenomas in Chinese women. The Journal of Nutrition. 140: 1294-301. PMID 20484549 DOI: 10.3945/Jn.109.119719 |
0.535 |
|
| 2010 |
Harigopal M, Barlow WE, Tedeschi G, Porter PL, Yeh IT, Haskell C, Livingston R, Hortobagyi GN, Sledge G, Shapiro C, Ingle JN, Rimm DL, Hayes DF. Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome. The American Journal of Pathology. 176: 1639-47. PMID 20150438 DOI: 10.2353/Ajpath.2010.090711 |
0.383 |
|
| 2010 |
Sgroi D, Finkelstein D, Shepherd L, Ingle J, Rimm D, Sasano H, Porter P, Pins M, Paik S, Ristimaki A, Pritchard K, Tu D, Goss P. Abstract P3-10-26: Quantitative Protein and Gene Expression Biomarkers of Tamoxifen and Letrozole Recurrence in the NCIC CTG MA.17 Cohort Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P3-10-26 |
0.547 |
|
| 2009 |
Porter PL. Global trends in breast cancer incidence and mortality. Salud PúBlica De MéXico. 51: s141-6. PMID 19967268 |
0.47 |
|
| 2009 |
Li CI, Daling JR, Porter PL, Tang MT, Malone KE. Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5312-8. PMID 19738113 DOI: 10.1200/Jco.2009.23.1597 |
0.56 |
|
| 2009 |
Li CI, Daling JR, Porter PL, Tang MT, Malone KE. Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer. Cancer Research. 69: 6865-70. PMID 19706753 DOI: 10.1158/0008-5472.Can-09-1355 |
0.565 |
|
| 2009 |
Tubbs R, Barlow WE, Budd GT, Swain E, Porter P, Gown A, Yeh IT, Sledge G, Shapiro C, Ingle J, Haskell C, Albain KS, Livingston R, Hayes DF. Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3881-6. PMID 19620488 DOI: 10.1200/Jco.2008.20.1566 |
0.449 |
|
| 2009 |
Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg EW, Coates RJ, Eley JW. The epidemiology of triple-negative breast cancer, including race. Cancer Causes & Control : Ccc. 20: 1071-82. PMID 19343511 DOI: 10.1007/S10552-009-9331-1 |
0.482 |
|
| 2009 |
Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, Malone KE. Risk factors for triple-negative breast cancer in women under the age of 45 years Cancer Epidemiology Biomarkers and Prevention. 18: 1157-1166. PMID 19336554 DOI: 10.1158/1055-9965.Epi-08-1005 |
0.57 |
|
| 2009 |
Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG, Eley JW. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Research and Treatment. 113: 357-70. PMID 18324472 DOI: 10.1007/S10549-008-9926-3 |
0.416 |
|
| 2009 |
Lund M, Eley J, O'Regan R, Gabram S, Saavedra H, Liff J, Brawley O, Porter P. Molecular differences between the triple negative tumors of African-American women and white women. Cancer Research. 69: 2087. DOI: 10.1158/0008-5472.Sabcs-2087 |
0.359 |
|
| 2008 |
Beaber EF, Holt VL, Malone KE, Porter PL, Daling JR, Li CI. Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3427-34. PMID 19064558 DOI: 10.1158/1055-9965.Epi-08-0641 |
0.492 |
|
| 2008 |
Mathes RW, Malone KE, Daling JR, Davis S, Lucas SM, Porter PL, Li CI. Migraine in postmenopausal women and the risk of invasive breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3116-22. PMID 18990752 DOI: 10.1158/1055-9965.Epi-08-0527 |
0.491 |
|
| 2008 |
McTiernan A, Porter P, Potter JD. Breast cancer prevention in countries with diverse resources Cancer. 113: 2325-2330. PMID 18837024 DOI: 10.1002/Cncr.23829 |
0.533 |
|
| 2008 |
Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer. 113: 1521-6. PMID 18726992 DOI: 10.1002/Cncr.23786 |
0.497 |
|
| 2008 |
Reding KW, Daling JR, Doody DR, O'Brien CA, Porter PL, Malone KE. Effect of prediagnostic alcohol consumption on survival after breast cancer in young women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1988-96. PMID 18664549 DOI: 10.1158/1055-9965.Epi-07-2897 |
0.498 |
|
| 2008 |
Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2078-86. PMID 18664548 DOI: 10.1158/1055-9965.Epi-08-0206 |
0.469 |
|
| 2008 |
Gadi VK, Malone KE, Guthrie KA, Porter PL, Nelson JL. Case-control study of fetal microchimerism and breast cancer. Plos One. 3: e1706. PMID 18320027 DOI: 10.1371/Journal.Pone.0001706 |
0.515 |
|
| 2008 |
Porter P. "Westernizing" women's risks? Breast cancer in lower-income countries. The New England Journal of Medicine. 358: 213-6. PMID 18199859 DOI: 10.1056/NEJMp0708307 |
0.5 |
|
| 2008 |
Mathes RW, Malone KE, Daling JR, Porter PL, Li CI. Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 67-72. PMID 18199712 DOI: 10.1158/1055-9965.Epi-07-0765 |
0.399 |
|
| 2008 |
Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, Lin MG, Yuan X, Daling JR. Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 43-50. PMID 18199710 DOI: 10.1158/1055-9965.Epi-07-0558 |
0.422 |
|
| 2007 |
Lampe JW, Nishino Y, Ray RM, Wu C, Li W, Lin MG, Gao DL, Hu Y, Shannon J, Stalsberg H, Porter PL, Frankenfeld CL, Wähälä K, Thomas DB. Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2579-86. PMID 18086761 DOI: 10.1158/1055-9965.Epi-07-0368 |
0.557 |
|
| 2007 |
Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, Thorne NP, Costa JL, Pinder SE, van de Wiel MA, Green AR, Ellis IO, Porter PL, Tavaré S, Brenton JD, Ylstra B, et al. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biology. 8: R215. PMID 17925008 DOI: 10.1186/Gb-2007-8-10-R215 |
0.496 |
|
| 2007 |
Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Moorman PG, Kaufman JS, Cai J, Porter PL, Brinton LA, Eley JW, Coates RJ. Oral contraceptives and survival in breast cancer patients aged 20 to 54 years. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1822-7. PMID 17855700 DOI: 10.1158/1055-9965.Epi-07-0053 |
0.393 |
|
| 2007 |
Hahn KM, Bondy ML, Selvan M, Lund MJ, Liff JM, Flagg EW, Brinton LA, Porter P, Eley JW, Coates RJ. Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. American Journal of Epidemiology. 166: 1035-44. PMID 17690220 DOI: 10.1093/Aje/Kwm177 |
0.51 |
|
| 2007 |
Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Kaufman JS, Moorman PG, Cai J, Olshan AF, Porter PL, Brinton LA, Eley JW, Coates RJ. Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Research and Treatment. 103: 93-102. PMID 17004111 DOI: 10.1007/S10549-006-9346-1 |
0.455 |
|
| 2006 |
Abrahamson PE, Gammon MD, Lund MJ, Flagg EW, Porter PL, Stevens J, Swanson CA, Brinton LA, Eley JW, Coates RJ. General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1871-7. PMID 17035393 DOI: 10.1158/1055-9965.Epi-06-0356 |
0.318 |
|
| 2006 |
Abrahamson PE, Gammon MD, Lund MJ, Britton JA, Marshall SW, Flagg EW, Porter PL, Brinton LA, Eley JW, Coates RJ. Recreational physical activity and survival among young women with breast cancer. Cancer. 107: 1777-85. PMID 16967443 DOI: 10.1002/Cncr.22201 |
0.349 |
|
| 2005 |
Gao DL, Thomas DB, Ray RM, Wang WW, Allison CJ, Chen FL, Porter P, Hu YW, Zhao GL, Pan LD, Li WJ, Wu CY, Coriaty Z, Evans I, Lin MG, et al. [Randomized trial of breast self-examination in 266,064 women in Shanghai]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 27: 350-4. PMID 16117898 |
0.459 |
|
| 2005 |
Aiello EJ, Buist DS, White E, Porter PL. Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 662-8. PMID 15767347 DOI: 10.1158/1055-9965.EPI-04-0327 |
0.555 |
|
| 2005 |
Shannon J, Ray R, Wu C, Nelson Z, Gao DL, Li W, Hu W, Lampe J, Horner N, Satia J, Patterson R, Fitzgibbons D, Porter P, Thomas D. Food and botanical groupings and risk of breast cancer: a case-control study in Shanghai, China. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 81-90. PMID 15668480 |
0.543 |
|
| 2004 |
Wu C, Ray RM, Lin MG, Gao DL, Horner NK, Nelson ZC, Lampe JW, Hu YW, Shannon J, Stalsberg H, Li W, Fitzgibbons D, Porter P, Patterson RE, Satia JA, et al. A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000. American Journal of Epidemiology. 160: 945-60. PMID 15522851 DOI: 10.1093/Aje/Kwh318 |
0.46 |
|
| 2004 |
Buist DS, Porter PL, Lehman C, Taplin SH, White E. Factors contributing to mammography failure in women aged 40-49 years. Journal of the National Cancer Institute. 96: 1432-40. PMID 15467032 DOI: 10.1093/jnci/djh269 |
0.429 |
|
| 2004 |
Sparks R, Ulrich CM, Bigler J, Tworoger SS, Yasui Y, Rajan KB, Porter P, Stanczyk FZ, Ballard-Barbash R, Yuan X, Lin MG, McVarish L, Aiello EJ, McTiernan A. UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Research : Bcr. 6: R488-98. PMID 15318931 DOI: 10.1186/Bcr818 |
0.399 |
|
| 2004 |
Porter PL, Lund MJ, Lin MG, Yuan X, Liff JM, Flagg EW, Coates RJ, Eley JW. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma. Cancer. 100: 2533-42. PMID 15197793 DOI: 10.1002/Cncr.20279 |
0.376 |
|
| 2004 |
Oestreicher N, White E, Malone KE, Porter PL. Hormonal factors and breast tumor proliferation: do factors that affect cancer risk also affect tumor growth? Breast Cancer Research and Treatment. 85: 133-42. PMID 15111771 DOI: 10.1023/B:BREA.0000025402.70958.3e |
0.5 |
|
| 2004 |
Suter NM, Ray RM, Hu YW, Lin MG, Porter P, Gao DL, Zaucha RE, Iwasaki LM, Sabacan LP, Langlois MC, Thomas DB, Ostrander EA. BRCA1 and BRCA2 Mutations in Women from Shanghai China Cancer Epidemiology Biomarkers and Prevention. 13: 181-189. PMID 14973102 DOI: 10.1158/1055-9965.Epi-03-0196 |
0.522 |
|
| 2004 |
Foulkes WD, Brunet JS, Stefansson IM, Straume O, Chappuis PO, Bégin LR, Hamel N, Goffin JR, Wong N, Trudel M, Kapusta L, Porter P, Akslen LA. The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer Research. 64: 830-5. PMID 14871808 DOI: 10.1158/0008-5472.CAN-03-2970 |
0.429 |
|
| 2003 |
Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Daling JR. The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 1061-6. PMID 14578143 |
0.432 |
|
| 2003 |
Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Daling JR. Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age. International Journal of Cancer. Journal International Du Cancer. 107: 647-51. PMID 14520705 DOI: 10.1002/Ijc.11465 |
0.39 |
|
| 2003 |
Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, Daling JR. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. Jama. 289: 3254-63. PMID 12824206 DOI: 10.1001/jama.289.24.3254 |
0.47 |
|
| 2002 |
Madeleine MM, Brumback B, Cushing-Haugen KL, Schwartz SM, Daling JR, Smith AG, Nelson JL, Porter P, Shera KA, McDougall JK, Galloway DA. Human leukocyte antigen class II and cervical cancer risk: a population-based study. The Journal of Infectious Diseases. 186: 1565-74. PMID 12447731 DOI: 10.1086/345285 |
0.313 |
|
| 2002 |
Oestreicher N, White E, Lehman CD, Mandelson MT, Porter PL, Taplin SH. Predictors of sensitivity of clinical breast examination (CBE). Breast Cancer Research and Treatment. 76: 73-81. PMID 12408378 DOI: 10.1023/A:1020280623807 |
0.461 |
|
| 2002 |
Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, Porter P, Hu YW, Zhao GL, Pan LD, Li W, Wu C, Coriaty Z, Evans I, Lin MG, et al. Randomized trial of breast self-examination in Shanghai: final results. Journal of the National Cancer Institute. 94: 1445-57. PMID 12359854 DOI: 10.1093/Jnci/94.19.1445 |
0.528 |
|
| 2002 |
Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL. The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 235-41. PMID 11895871 |
0.403 |
|
| 2001 |
Schubert E, Cousens L, Hsu L, Glogovac J, Reid B, Self S, Rabinovich P, Porter P. Allelic imbalance in routinely processed breast tumors determined by Affymetrix HuSNP array Nature Genetics. 27: 85-85. DOI: 10.1038/87288 |
0.491 |
|
| 2000 |
Li CI, Anderson BO, Porter P, Holt SK, Daling JR, Moe RE. Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer. 88: 2561-9. PMID 10861434 DOI: 10.1002/1097-0142(20000601)88:11<2561::Aid-Cncr19>3.0.Co;2-X |
0.401 |
|
| 1997 |
Thomas DB, Gao DL, Self SG, Allison CJ, Tao Y, Mahloch J, Ray R, Qin Q, Presley R, Porter P. Randomized trial of breast self-examination in Shanghai: methodology and preliminary results. Journal of the National Cancer Institute. 89: 355-65. PMID 9060957 DOI: 10.1093/Jnci/89.5.355 |
0.553 |
|
| Show low-probability matches. |